Ablation of Metastatic Ovarian Carcinoma with the Argon Beam Coagulator: Pathologic Analysis of Tumor Destruction
Authors:
- Robert E. BristowRBRobert E. Bristow
- Ann E. Smith SehdevASAnn E. Smith Sehdev
- Howard S. KaufmanHKHoward S. Kaufman
- F.J. MontzFMF.J. Montz
- 1 October 2001
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 83 (1) , 49-55
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinomaCancer, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective StudyGynecologic Oncology, 1998
- The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian CancerGynecologic Oncology, 1995
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1994
- Debulking and intervention surgeryAnnals of Oncology, 1993
- Peritoneal Implant Elimination during Cytoreductive Surgery for Ovarian Cancer: Impact on SurvivalGynecologic Oncology, 1993
- Argon Beam Coagulation compared with cryoablation of ventricular subendocardiumThe Annals of Thoracic Surgery, 1993
- Electrosurgical debulking of ovarian cancer: A new technique using the argon beam coagulatorGynecologic Oncology, 1990
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984